18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma
Background We sought to investigate the clinical features and 18F‐FDG PET/CT characteristics of pulmonary sclerosing pneumocytoma (PSP). Methods We retrospectively reviewed and comparatively analyzed 18F‐FDG PET/CT imaging results of 22 patients with diagnosed PSP in our hospital from November 2009...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-07-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.13100 |
| _version_ | 1818359733594095616 |
|---|---|
| author | Jie Xu Youwen Dong Guotao Yin Wei Jiang Zhen Yang Wengui Xu Lei Zhu |
| author_facet | Jie Xu Youwen Dong Guotao Yin Wei Jiang Zhen Yang Wengui Xu Lei Zhu |
| author_sort | Jie Xu |
| collection | DOAJ |
| description | Background We sought to investigate the clinical features and 18F‐FDG PET/CT characteristics of pulmonary sclerosing pneumocytoma (PSP). Methods We retrospectively reviewed and comparatively analyzed 18F‐FDG PET/CT imaging results of 22 patients with diagnosed PSP in our hospital from November 2009 to September 2015. Results The SUVmax in tumors was positively correlated with tumor size in typical PSPs (R = 0.806, R2 = 0.650, P = 0.001); however, the SUVmax in tumors had no significant correlation with tumor size of atypical PSPs (R = 0.479, R2 = 0.229, P = 0.162), and the degree of correlation between them attenuated when atypical PSPs were included (R = 0.518, R2 = 0.268, P = 0.011). A majority (90%) of atypical PSPs were found in males. Symptomatic patients showed a higher SUVmax than the asymptomatic group (5.68 ± 3.63 vs. 2.76 ± 1.18, respectively, P = 0.002). Conclusion Tumor size and clinical features may be associated with increased FDG uptake in PSPs. Morphological differences may affect the correlation between tumor size and SUVmax in PSPs. The atypical form of PSP may be more common in men. |
| first_indexed | 2024-12-13T20:49:35Z |
| format | Article |
| id | doaj.art-03022a98b27a4a2b89bc5324a879d6c9 |
| institution | Directory Open Access Journal |
| issn | 1759-7706 1759-7714 |
| language | English |
| last_indexed | 2024-12-13T20:49:35Z |
| publishDate | 2019-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | Thoracic Cancer |
| spelling | doaj.art-03022a98b27a4a2b89bc5324a879d6c92022-12-21T23:31:54ZengWileyThoracic Cancer1759-77061759-77142019-07-011071552156010.1111/1759-7714.1310018F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytomaJie Xu0Youwen Dong1Guotao Yin2Wei Jiang3Zhen Yang4Wengui Xu5Lei Zhu6Department of Senior Ward, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaImaging Center The Affiliated Hospital of Jining Medical University Jining ChinaDepartment of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaDepartment of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaDepartment of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaDepartment of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaDepartment of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaBackground We sought to investigate the clinical features and 18F‐FDG PET/CT characteristics of pulmonary sclerosing pneumocytoma (PSP). Methods We retrospectively reviewed and comparatively analyzed 18F‐FDG PET/CT imaging results of 22 patients with diagnosed PSP in our hospital from November 2009 to September 2015. Results The SUVmax in tumors was positively correlated with tumor size in typical PSPs (R = 0.806, R2 = 0.650, P = 0.001); however, the SUVmax in tumors had no significant correlation with tumor size of atypical PSPs (R = 0.479, R2 = 0.229, P = 0.162), and the degree of correlation between them attenuated when atypical PSPs were included (R = 0.518, R2 = 0.268, P = 0.011). A majority (90%) of atypical PSPs were found in males. Symptomatic patients showed a higher SUVmax than the asymptomatic group (5.68 ± 3.63 vs. 2.76 ± 1.18, respectively, P = 0.002). Conclusion Tumor size and clinical features may be associated with increased FDG uptake in PSPs. Morphological differences may affect the correlation between tumor size and SUVmax in PSPs. The atypical form of PSP may be more common in men.https://doi.org/10.1111/1759-7714.1310018Fluorine 2‐fluoro‐2‐deoxy‐d‐glucosepositron emission tomography and computed tomographypulmonary sclerosing pneumocytoma |
| spellingShingle | Jie Xu Youwen Dong Guotao Yin Wei Jiang Zhen Yang Wengui Xu Lei Zhu 18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma Thoracic Cancer 18Fluorine 2‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography and computed tomography pulmonary sclerosing pneumocytoma |
| title | 18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma |
| title_full | 18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma |
| title_fullStr | 18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma |
| title_full_unstemmed | 18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma |
| title_short | 18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma |
| title_sort | 18f fdg pet ct imaging a supplementary understanding of pulmonary sclerosing pneumocytoma |
| topic | 18Fluorine 2‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography and computed tomography pulmonary sclerosing pneumocytoma |
| url | https://doi.org/10.1111/1759-7714.13100 |
| work_keys_str_mv | AT jiexu 18ffdgpetctimagingasupplementaryunderstandingofpulmonarysclerosingpneumocytoma AT youwendong 18ffdgpetctimagingasupplementaryunderstandingofpulmonarysclerosingpneumocytoma AT guotaoyin 18ffdgpetctimagingasupplementaryunderstandingofpulmonarysclerosingpneumocytoma AT weijiang 18ffdgpetctimagingasupplementaryunderstandingofpulmonarysclerosingpneumocytoma AT zhenyang 18ffdgpetctimagingasupplementaryunderstandingofpulmonarysclerosingpneumocytoma AT wenguixu 18ffdgpetctimagingasupplementaryunderstandingofpulmonarysclerosingpneumocytoma AT leizhu 18ffdgpetctimagingasupplementaryunderstandingofpulmonarysclerosingpneumocytoma |